Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 239.19B, Merck(MRK) trades at $96.37. The stock has a price-to-earnings ratio of 12.28 and currently yields dividends of 3.5%.
As of 2025-11-18, Merck(MRK) stock has fluctuated between $92.11 and $97.29. The current price stands at $96.37, placing the stock +4.6% above today's low and -0.9% off the high.
The Merck(MRK)'s current trading volume is 12.02M, compared to an average daily volume of 12.91M.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.07 at its peak.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.07 at its peak.
MRK News
Merck (MRK) announced positive topline results from the Phase 2 CADENCE study evaluating Winrevair in adults for the treatment of combined post- and precapillar...
In a report released yesterday, Tim Anderson from Bank of America Securities reiterated a Buy rating on Merck & Company, with a price target of $105.00. Meet Yo...
BofA analyst Tim Anderson raised the firm’s price target on Merck (MRK) to $105 from $98 and keeps a Buy rating on the shares. The Cidara (CDTX) deal is a “reas...
Analyst ratings
59%
of 29 ratingsMore MRK News
Merck (MRK) said it anticipates a commercial opportunity surpassing $5B from Cidara’s (CDTX) experimental flu drug, and does not expect it to require a review b...
As of Nov. 17, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading de...
Merck (MRK) shares traded close to flat today, holding steady as investors weigh recent performance and updates from the pharmaceutical sector. Despite minimal...
Merck & Company, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Terence Flynn from Morgan Stanley maintained a Hold ra...
Insiders have been trading these 5 stocks: ((LLY)), ((GM)), ((IONQ)), ((MRK)) and ((MARA)). Here is a breakdown of their recent trades and their value. Meet Yo...
Close Key Takeaways Merck agreed to pay $9.2 billion to purchase Cidara Therapeutics, looking to cash in on the firm's experimental flu treatment. The $221.50...
(RTTNews) - Cidara Therapeutics, Inc. (CDTX) climbed 105.68% to $217.99, up $112.00, after it announced that Merck & Co. will acquire all outstanding shares for...
